BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 570784)

  • 1. [Treatment of hyperprolactinemic conditions with bromoergocryptine].
    Sas M; Godó G; Morvay J
    Zentralbl Gynakol; 1978; 100(22):1501-7. PubMed ID: 570784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment.
    Barreca P; Giannola C; Palisi F
    Acta Eur Fertil; 1978 Mar; 9(1):21-9. PubMed ID: 567920
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bromocriptine treatment of amenorrhea with hyperprolactinemia and galactorrhea].
    Hiroi M; Kawakoshi S; Kaneko N
    Horumon To Rinsho; 1983 Jan; 31(1):95-9. PubMed ID: 6682727
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
    Abraham G
    Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum prolactin level and bromoergocriptine therapy in galactorrhea and oligo- or amenorrhea].
    Baron J; Warenik-Szymankiewicz A; Chwalisz K
    Ginekol Pol; 1981 Jun; 52(6):517-20. PubMed ID: 7197249
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the long-term use of parlodel in different forms of lactorrhea].
    Mel'nichenko GA; Pishulin AA; Gitel' EG; Nazarenko VA
    Sov Med; 1984; (1):59-64. PubMed ID: 6701657
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment with 2-brom-alfa ergocriptine in the syndrome amenorrhea-galactorrhea.
    Sirbu P; Cioltei A; Simionescu L; Dumbravescu A; Sedan E; Titiriga L; Mîtulescu V
    Acta Eur Fertil; 1979 Dec; 10(4):177. PubMed ID: 552769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine. Clinical experience in the induction of pregnancy in amenorrhea-galactorrhea syndrome.
    Zárate A; Canales ES; Forsbach G; Fernández-Lazala R
    Obstet Gynecol; 1978 Oct; 52(4):442-4. PubMed ID: 714326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM; Siler-Khodr TM
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Longtime study on bromoergocryptine therapy and pyridoxine therapy of amenorrhea-galactorrhea].
    Schindler AE; Plieninger M; Zubke W; Göser R; Keller E
    Arch Gynecol; 1979 Jul; 228(1-4):596. PubMed ID: 573598
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine-induced pregnancies in the amenorrhoea-galactorrhoea syndrome.
    Mustaffa BE; Khalid BA; Satgunasingam N; Adeeb N; Tan PL; Chandran S
    Med J Malaysia; 1983 Sep; 38(3):237-43. PubMed ID: 6672568
    [No Abstract]   [Full Text] [Related]  

  • 15. [2-bromo-alpha-ergocryptine in the treatment of luteal insufficiency].
    Nappi C; Votino F; Mattera P; Montemagno U
    Minerva Ginecol; 1979 Apr; 31(4):273-80. PubMed ID: 572516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of the amenorrhea-galatorrhea-anovulation syndrome with bromocryptin and the results].
    Markovski N; Ivanov S
    Akush Ginekol (Sofiia); 1980; 19(1):46-52. PubMed ID: 7377513
    [No Abstract]   [Full Text] [Related]  

  • 17. [Remote results of treatment of galactorrhea-amenorrhea syndromes and functional sterility with increased prolactin concentration by means of bromocriptine (Parlodel-Sandoz)].
    Tomala J; Dudkiewicz J; Blecharz AJ
    Ginekol Pol; 1980 Mar; 51(3):255-8. PubMed ID: 6771191
    [No Abstract]   [Full Text] [Related]  

  • 18. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
    Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
    Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bromoergocryptine (CB 154) and pregnancy. Notes on 2 cases].
    Pagliani A; Modena G
    Minerva Ginecol; 1979 Jun; 31(6):461-5. PubMed ID: 492588
    [No Abstract]   [Full Text] [Related]  

  • 20. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
    Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
    J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.